DEPLOYDatabase

Deployment

Ion Endoluminal System at United States

Intuitive Surgical's Ion Endoluminal System is a robotic-assisted bronchoscopy platform for minimally invasive biopsy of peripheral lung nodules. It uses an ultra-thin, shape-sensing maneuverable catheter with PlanPoint CT-based airway planning to reach lesions deep in the peripheral lung. FDA 510(k) cleared in February 2019 and commercially deployed across US hospitals, with subsequent AI and advanced-imaging integration clearances.

Ion Endoluminal System by Intuitive Surgical · Catalog entry · 2 sources · not yet field-verified · Surgical robots

Track Ion Endoluminal System at United States

Recent coverage

See all coverage →

Machine-readable surfaces

Footage

PRIMARY SOURCE
Courtesy of Intuitive Surgical

Intuitive Surgical's introduction of Ion, its robotic-assisted bronchoscopy platform for minimally invasive peripheral-lung biopsy. Physician-driven via a shape-sensing catheter; not autonomous.

Ion Endoluminal System (Intuitive Surgical) operating in United States. Status: operational.

Safety record

No incidents on record for Ion Endoluminal System at United States.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Catalog entry · 2 sources · not yet field-verifiedhow tiers work →
Last updated
2026-07-23
Model
Ion Endoluminal System
Company
Intuitive Surgical
Location
United States
Status
operational
First seen
2019-06-01
ID
a91431a1-b441-4e71-b7f6-fbf6277ef870

Timeline

  1. Jun 2019
    First recorded
    Ion Endoluminal System first documented operating at United States.
  2. Jul 2026
    Current status: operational, reviewed
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Ion Endoluminal System operates in United States. Explore the full verified map:

Sources (2)

  1. Intuitive Ion robotic bronchoscopy system: product page · https://www.intuitive.com/en-us/products-and-services/ion
  2. Intuitive: FDA clearance for Ion endoluminal system, 2019 · https://investors.intuitive.com/news-releases/news-release-details/intuitive-announces-fda-clearance-ion-endoluminal-system
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-07-23

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-23

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source
1
primary-company-ir
Company IR disclosure

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Ion Endoluminal System at United States.

Common questions

What is the Ion Endoluminal System deployment at United States?
Ion Endoluminal System, built by Intuitive Surgical, is recorded as a deployment at United States on the DEPLOY registry. Intuitive Surgical operates the deployment directly.
Who operates Ion Endoluminal System at United States?
Intuitive Surgical, the manufacturer of Ion Endoluminal System, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the Ion Endoluminal System deployment at United States go live?
The deployment is recorded as starting June 1, 2019 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the Ion Endoluminal System deployment at United States?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.